EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

A systematic review of therapeutic options for lymphocytic esophagitis

Bachviet Nguyen iD, Chun Fang Cheng, Fahd Jowhari iD

Diseases of the Esophagus · 2025

DOI: 10.1093/dote/doaf112 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Diseases of the Esophagus, 2025. Verfasst von Bachviet Nguyen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of British Columbia, 13750, 96 Ave. Critical Care Tower, 3rd Floor, Surrey, British Columbia, V3V 1Z2, Canada. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Esophagitis. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lymphocytic esophagitis (LyE) is a novel rare esophageal disorder characterized by intraepithelial lymphocytic infiltration of the esophagus in a peripapillary distribution, without the involvement of granulocytes. The optimal treatment strategy for this condition remains uncertain. We aimed to synthesize the current evidence for the treatment of lymphocytic esophagitis.

Methods

We performed a systematic review according to PRISMA guidelines, searching MEDLINE, Embase, and Google Scholar. Studies with non-primary data or insufficient treatment data were excluded. Descriptive statistics were performed on patient demographics and treatment outcomes.

Results

Thirty nine articles from 2012–2024 were included (154 patients total). Proton pump inhibitors (PPIs) were the most common initial therapy for LyE (n = 65), followed by topical steroids (n = 23). A greater proportion of patients experienced a symptomatic, endoscopic, and histologic response from the initial use of topical steroids as monotherapy or part of combination therapy (with PPIs) compared to PPIs alone. Symptomatic recurrence was more common after initial use of topical steroids compared to PPIs. Balloon dilation was effective in relieving symptomatic esophageal dysphagia. Other therapies included biologics, endoscopic botulinum injections, sucralfate, and tacrolimus. The average follow-up duration was 8.98 months.

Conclusions

For patients with LyE, topical steroids seem to provide greater symptomatic and histologic benefit compared to PPIs, although recurrence is more common. For patients not already on acid suppression therapy, PPIs may still be a reasonable first-line option, especially when prioritizing safety. Further prospective studies are needed to formally assess the comparative safety and efficacy of the various treatment modalities, including novel immunosuppressive therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsEsophagitisHumansTreatment OutcomeMaleFemaleDeglutition DisordersMiddle AgedLymphocytesRecurrenceTacrolimusSteroidsAgedDilatationAdult

Stichwörter der Autor:innen

biologicsbudesonidediseases of the esophagusesophagitislymphocytic esophagitisproton pump inhibitors (PPIs)tacrolimus

Substanzen

Proton Pump InhibitorsTacrolimusSteroids

Autor:innen und Institutionen

  • Department of Medicine, University of British Columbia, 13750, 96 Ave. Critical Care Tower, 3rd Floor, Surrey, British Columbia, V3V 1Z2, Canada.
  • Department of Statistics, University of British Columbia, 3182 Earth Sciences Building, 2207 Main Mall, Vancouver V6T 1Z4, Canada.
  • Division of Gastroenterology, University of British Columbia Okanagan, 564 Leon Avenue, Kelowna, V1Y 6J6, Canada.

ORCID-Profile: Bachviet Nguyen, Fahd Jowhari

Zitieren

APA

Nguyen, B., Cheng, C. F., & Jowhari, F. (2025). A systematic review of therapeutic options for lymphocytic esophagitis. Diseases of the Esophagus. https://doi.org/10.1093/dote/doaf112

Vancouver

Nguyen B, Cheng CF, Jowhari F. A systematic review of therapeutic options for lymphocytic esophagitis. Diseases of the Esophagus. 2025. doi:10.1093/dote/doaf112

BibTeX
@article{Nguyen2025,
  author = {Nguyen, Bachviet and Cheng, Chun Fang and Jowhari, Fahd},
  title = {A systematic review of therapeutic options for lymphocytic esophagitis},
  journal = {Diseases of the Esophagus},
  year = {2025},
  doi = {10.1093/dote/doaf112}
}
Kostenlos starten →